Contracting Opportunities

Cognition Therapeutics is currently conducting Phase 2 trials in Alzheimer’s disease (SHINE and START), dementia with Lewy bodies (SHIMMER), and geographic atrophy secondary to dry age-related macular degeneration (MAGNIFY). Vendors with experience in neurological and neuro-ophthalmic diseases concentrating in the clinical / non-clinical spaces should submit their information. Accepted vendors will be given opportunities to bid on services as needed on a rolling basis. Six immediate needs exist:

• Support for a digital recruitment campaigns;
• Patient travel solutions utilizing a travel agency-like platform;
• Decentralized study expertise focusing on bring the study to the patient’s home or community;
• Increasing underrepresented groups in our trials; and
• Expertise in data management (STDM, TLF, CSR), SAP, and final analysis
• Contract Sr. CPM, Sr. CRA Manager, and eTMF specialist (added February 9, 2024)

Cognition Therapeutics has been awarded grants from NIH for clinical trials SHINE, SHIMMER, and START. Qualified vendors will be considered for other federally funded opportunities as they become available. Information regarding our clinical trials can be found at www.cogrx.com/clinical-trials or www.clinicaltrials.gov. Cognition Therapeutics recognizes the importance and value brought by small and minority businesses, veteran-owned businesses, and women’s business enterprises to contracting opportunities. We actively encourage their participation.